1432 - Exploring Cell Wall Targets to Overcome Mycobacterium tuberculosis (Mtb): Ceftriaxone (CRO) Inhibits Ldt_Mt2, a Major Peptidoglycan (PG) Synthase

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

David C. Nguyen, MD

Physician
Louis Stokes Cleveland Veterans Affairs Medical Center
Cleveland, Ohio, United States

SR

Sarah N. Redmond, M.D.

University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Khalid M. Dousa, M.D.

Attending
Louis Stokes Cleveland VA Medical Center
Cleveland, Ohio, United States
CB

Christopher Bethel, MS

Research Assisitant
Louis Stokes Cleveland VA Medical Center
Cleveland, Ohio, United States
MT

Magdalena A. Taracila, MS

Research Assistant
Case Western Reserve University
Cleveland, Ohio, United States
QL

Qing Li, MS

Case Western Reserve University
Cleveland, Ohio, United States
SK

Sebastian G. Kurz, M.D.

Associate professor
University Hospitals of Tuebingen
Tuebingen, Baden-Wurttemberg, Germany
MP

Martin S. Pavelka, Jr., Ph.D.

University of Rochester Medical Center
Rochester, New York, United States
KP

Krisztina Papp-Wallace, Ph.D

Case Western Reserve University/ Louis Stokes Cleveland VA Medical Center
Cleveland, Ohio, United States
SH

Steven M. Holland, M.D.

Dr.
National Institutes of Health
Bethesda, Maryland, United States
BK

Barry N. Kreiswirth, Ph.D.

Professor
Center for Discovery and Innovation, Hakensack Meridian Health
Nutley, New Jersey, United States
HB

Henry Boom, M.D.

Case Western Reserve University / University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Robert A. Bonomo, MD

Associate Chief of Staff for Academic Affairs
Case Western Reserve University/ Louis Stokes Cleveland VA Medical Center
Cleveland, OH, United States